Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Sanofi”
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Non-seminomatous Germ-cell Tumors
France
- Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During PregnancyActive Not Recruiting
Sponsor: Sanofi
Pertussis (Whooping Cough)
France
- PRV-3279-2a Trial in Systemic LupusTerminated
Sponsor: Provention Bio, a Sanofi Company
Systemic Lupus Erythematosus
United States, China, Hong Kong, Puerto Rico
- Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell TransplantationActive Not Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Blood Cancer · Refractory Immune Cytopenias
United States
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Metastatic Castration-resistant Prostate Cancer
France
Sponsor: Sanofi
Influenza Immunization · Healthy Volunteers
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Chronic Asthma
Spain
Sponsor: Sanofi
Asthma
United States, Argentina, Brazil, Canada, Chile +9 more
- A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseCompleted
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Crohn Disease · Colitis, Ulcerative
United States, Austria, Belgium, Bulgaria, Canada +14 more
Sponsor: Sanofi
Crohn's Disease
United States, Australia, Belgium, China, Czechia +7 more
Sponsor: Sanofi
Plasma Cell Myeloma Refractory
United States, Australia, Canada, France, Israel +2 more
- China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPDRecruiting
Sponsor: Genzyme, a Sanofi Company
Glycogen Storage Disease Type II · Pompe's Disease
China
- Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in IndiaActive Not Recruiting
Sponsor: Sanofi
RSV Immunization
India
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne
Bronchiolitis · Pneumonia · Asthma
France
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne
RSV Infection · Children, Only · Outpatient · Otitis
France
Sponsor: Sanofi
Asthma
United States, Argentina, Brazil, Canada, Chile +9 more
Sponsor: Sanofi
Type 2 Diabetes (T2D)
China
- Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® MoleculeActive Not Recruiting
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, Argentina, Australia, Brazil, Canada +3 more
- Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaActive Not Recruiting
Sponsor: University of Washington
Recurrent Multiple Myeloma · Refractory Multiple Myeloma
United States
- Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLCActive Not Recruiting
Sponsor: The Netherlands Cancer Institute
Carcinoma, Non-Small-Cell Lung
Netherlands
Sponsor: Sanofi Pasteur, a Sanofi Company
Respiratory Syncytial Virus Infection · Healthy Volunteers · Human Metapneumovirus
United States, Puerto Rico
- ELISA in Relapsed/Refractory MMRecruiting
Sponsor: Massachusetts General Hospital
Relapsed Refractory Multiple Myeloma (RRMM) · Relapsed Refractory Multiple Myeloma
United States
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
United States, Belgium, Brazil, Denmark, Germany +2 more
- Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and OlderCompleted
Sponsor: Sanofi Pasteur, a Sanofi Company
Respiratory Syncytial Virus Infection · Healthy Volunteers
Australia, Chile, Colombia, Dominican Republic, Honduras +1 more
Sponsor: Sanofi
Eosinophilic Esophagitis
Germany